Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevnar 13 in Adults 55-74 Previously Vaccinated With PPSV23
NCT01654263Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2012
- Primary completion
- Aug 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Prevnar 13 in pneumococcal infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Oct 2012; status: completed.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT01654263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01654263.